Cigna (NYSE:CI) Trading 1.7% Higher

Cigna Corp (NYSE:CI) shares traded up 1.7% during mid-day trading on Friday . The stock traded as high as $185.77 and last traded at $178.32, 179,389 shares were traded during mid-day trading. A decline of 88% from the average session volume of 1,469,060 shares. The stock had previously closed at $175.34.

Several analysts have issued reports on the company. Citigroup upgraded Atara Biotherapeutics from a “sell” rating to a “neutral” rating and boosted their target price for the company from $23.00 to $24.00 in a research note on Monday, June 3rd. UBS Group set a $36.00 target price on Halliburton and gave the company a “buy” rating in a research note on Tuesday, April 23rd. Zacks Investment Research upgraded HB Fuller from a “sell” rating to a “hold” rating in a research note on Tuesday, June 11th. Goldman Sachs Group upgraded Puxin from a “neutral” rating to a “buy” rating and boosted their target price for the company from $51.00 to $56.00 in a research note on Friday, May 3rd. Finally, Morgan Stanley upgraded to an “overweight” rating and set a GBX 400 ($5.23) target price on the stock in a research note on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $217.40.

The company has a market cap of $68.00 billion, a P/E ratio of 12.60, a PEG ratio of 0.88 and a beta of 0.71. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.70 and a quick ratio of 0.70. The company’s 50-day simple moving average is $157.65.

Cigna (NYSE:CI) last posted its earnings results on Thursday, May 2nd. The health services provider reported $3.90 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.74 by $0.16. Cigna had a return on equity of 14.23% and a net margin of 4.11%. The business had revenue of $33.43 billion during the quarter, compared to analysts’ expectations of $32.79 billion. During the same period in the previous year, the business earned $4.11 earnings per share. The firm’s revenue was up 192.9% on a year-over-year basis. Sell-side analysts forecast that Cigna Corp will post 16.55 EPS for the current fiscal year.

Institutional investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP grew its position in shares of Cigna by 82.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,539,322 shares of the health services provider’s stock worth $672,215,000 after acquiring an additional 1,600,531 shares during the last quarter. Stifel Financial Corp grew its position in shares of Cigna by 98.5% during the fourth quarter. Stifel Financial Corp now owns 80,957 shares of the health services provider’s stock worth $15,414,000 after acquiring an additional 40,168 shares during the last quarter. Magnus Financial Group LLC bought a new position in shares of Cigna during the fourth quarter worth about $210,000. Geode Capital Management LLC grew its position in shares of Cigna by 61.3% during the fourth quarter. Geode Capital Management LLC now owns 4,939,173 shares of the health services provider’s stock worth $936,405,000 after acquiring an additional 1,876,556 shares during the last quarter. Finally, Lord Abbett & CO. LLC bought a new position in shares of Cigna during the fourth quarter worth about $2,676,000. Institutional investors and hedge funds own 88.18% of the company’s stock.

Cigna Company Profile (NYSE:CI)

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Article: Trade Deficit

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.